Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Solomon

Showing results (411-420 of 524) with videos related to

Pageof 53
Sort By:
ACR Open Rheumatology|November 17, 2020
Adverse Effects of Low-Dose Methotrexate in a Randomized Double-Blind Placebo-Controlled Trial: Adjudicated Hematologic and Skin Cancer Outcomes in the Cardiovascular Inflammation Reduction TrialKathleen M M Vanni, Nancy Berliner, Nina P Paynter, et al.
RMD Open|January 12, 2024
Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activityKaren Holten, Nina Paulshus Sundlisæter, Joseph Sexton, et al.
Arthritis Care & Research|April 26, 2016
Cost-Effectiveness of Tramadol and Oxycodone in the Treatment of Knee OsteoarthritisSavannah R Smith, Jeffrey N Katz, Jamie E Collins, et al.
Clinical and Experimental Rheumatology|October 17, 2013
Use of data from multiple registries in studying biologic discontinuation: challenges and opportunitiesKazuki Yoshida, Helga Radner, Arthur Kavanaugh, et al.
Rheumatology (Oxford, England)|September 18, 2010
Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential StudyChristine K Iannaccone, Yvonne C Lee, Jing Cui, et al.
The Journal of Rheumatology|May 2, 2021
Predicting Response to Tocilizumab Monotherapy in Rheumatoid Arthritis: A Real-world Data Analysis Using Machine LearningFredrik D Johansson, Jamie E Collins, Vincent Yau, et al.
Nature Reviews. Disease Primers|February 9, 2018
Rheumatoid arthritisJosef S Smolen, Daniel Aletaha, Anne Barton, et al.
Journal of General Internal Medicine|March 16, 2007
Improving care of patients at-risk for osteoporosis: a randomized controlled trialDaniel H Solomon, Jennifer M Polinski, Margaret Stedman, et al.
Plos One|January 24, 2019
Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritisSiri Lillegraven, Jeffrey D Greenberg, George W Reed, et al.
Arthritis Care & Research|January 15, 2021
Development of a Medicare Claims-Based Model to Predict Persistent High-Dose Opioid Use After Total Knee ReplacementChandrasekar Gopalakrishnan, Rishi J Desai, Jessica M Franklin, et al.
Pageof 53

Showing results (411-420 of 524) with videos related to

Sort By:
Pageof 53
ACR Open Rheumatology|November 17, 2020
Adverse Effects of Low-Dose Methotrexate in a Randomized Double-Blind Placebo-Controlled Trial: Adjudicated Hematologic and Skin Cancer Outcomes in the Cardiovascular Inflammation Reduction TrialKathleen M M Vanni, Nancy Berliner, Nina P Paynter, et al.
RMD Open|January 12, 2024
Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activityKaren Holten, Nina Paulshus Sundlisæter, Joseph Sexton, et al.
Arthritis Care & Research|April 26, 2016
Cost-Effectiveness of Tramadol and Oxycodone in the Treatment of Knee OsteoarthritisSavannah R Smith, Jeffrey N Katz, Jamie E Collins, et al.
Clinical and Experimental Rheumatology|October 17, 2013
Use of data from multiple registries in studying biologic discontinuation: challenges and opportunitiesKazuki Yoshida, Helga Radner, Arthur Kavanaugh, et al.
Rheumatology (Oxford, England)|September 18, 2010
Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential StudyChristine K Iannaccone, Yvonne C Lee, Jing Cui, et al.
The Journal of Rheumatology|May 2, 2021
Predicting Response to Tocilizumab Monotherapy in Rheumatoid Arthritis: A Real-world Data Analysis Using Machine LearningFredrik D Johansson, Jamie E Collins, Vincent Yau, et al.
Nature Reviews. Disease Primers|February 9, 2018
Rheumatoid arthritisJosef S Smolen, Daniel Aletaha, Anne Barton, et al.
Journal of General Internal Medicine|March 16, 2007
Improving care of patients at-risk for osteoporosis: a randomized controlled trialDaniel H Solomon, Jennifer M Polinski, Margaret Stedman, et al.
Plos One|January 24, 2019
Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritisSiri Lillegraven, Jeffrey D Greenberg, George W Reed, et al.
Arthritis Care & Research|January 15, 2021
Development of a Medicare Claims-Based Model to Predict Persistent High-Dose Opioid Use After Total Knee ReplacementChandrasekar Gopalakrishnan, Rishi J Desai, Jessica M Franklin, et al.
Pageof 53